BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Markus BH, Dickson ER, Grambsch PM, Fleming TR, Mazzaferro V, Klintmalm GB, Wiesner RH, Van Thiel DH, Starzl TE. Efficiency of liver transplantation in patients with primary biliary cirrhosis. N Engl J Med. 1989;320:1709-1713. [PMID: 2659986 DOI: 10.1056/nejm198906293202602] [Cited by in Crossref: 178] [Cited by in F6Publishing: 18] [Article Influence: 5.4] [Reference Citation Analysis]
Number Citing Articles
1 Stieber AC, Gordon RD, Todo S, Tzakis AG, Fung JJ, Casavilla A, Selby RR, Mieles L, Reyes J, Starzl TE. Liver transplantation in patients over sixty years of age. Transplantation 1991;51:271-3. [PMID: 1987699 DOI: 10.1097/00007890-199101000-00046] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 1.2] [Reference Citation Analysis]
2 Genda T, Ichida T, Sakisaka S, Sata M, Tanaka E, Inui A, Egawa H, Umeshita K, Furukawa H, Kawasaki S. Waiting list mortality of patients with primary biliary cirrhosis in the Japanese transplant allocation system. J Gastroenterol. 2014;49:324-331. [PMID: 23478939 DOI: 10.1007/s00535-013-0782-5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
3 Khungar V, Goldberg DS. Liver Transplantation for Cholestatic Liver Diseases in Adults. Clin Liver Dis. 2016;20:191-203. [PMID: 26593299 DOI: 10.1016/j.cld.2015.08.011] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
4 Schnitzbauer AA, Bechstein WO. Equitable distribution in rare indications for liver transplantation: the dilemma of the too small tablecloth continues! Transpl Int 2017;30:451-3. [PMID: 28226189 DOI: 10.1111/tri.12942] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
5 Brayman KL, Morel P, Sutherland DE, Najarian JS, Payne WD. Liver transplantation: annotated references. Curr Opin Immunol 1989;1:1236-40. [PMID: 2679762 DOI: 10.1016/0952-7915(89)90022-8] [Reference Citation Analysis]
6 Ghosh L, Jiang J, Sun Y, Zhou H. Failure time regression with continuous informative auxiliary covariates. J Stat Distrib Appl 2015;2:2. [PMID: 26594610 DOI: 10.1186/s40488-015-0026-8] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
7 Kubicka S, Kühnel F, Flemming P, Hain B, Kezmic N, Rudolph KL, Manns M, Meier PN. K-ras mutations in the bile of patients with primary sclerosing cholangitis. Gut 2001;48:403-8. [PMID: 11171833 DOI: 10.1136/gut.48.3.403] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 1.8] [Reference Citation Analysis]
8 Bateson MC. New directions in primary biliary cirrhosis. BMJ 1990;301:1290-1. [PMID: 2271850 DOI: 10.1136/bmj.301.6764.1290] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
9 Fleming TR, Ellenberg SS. Evaluating interventions for Ebola: The need for randomized trials. Clin Trials 2016;13:6-9. [PMID: 26768563 DOI: 10.1177/1740774515616944] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
10 Malik A, Kardashian AA, Zakharia K, Bowlus CL, Tabibian JH. Preventative care in cholestatic liver disease: Pearls for the specialist and subspecialist. Liver Res 2019;3:118-27. [PMID: 32042471 DOI: 10.1016/j.livres.2019.04.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
11 Kouroumalis E, Notas G. Primary biliary cirrhosis: From bench to bedside. World J Gastrointest Pharmacol Ther 2015; 6(3): 32-58 [PMID: 26261733 DOI: 10.4292/wjgpt.v6.i3.32] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
12 Starzl TE, Demetris AJ, Van Thiel D. Liver transplantation (1). N Engl J Med. 1989;321:1014-1022. [PMID: 2674716 DOI: 10.1056/nejm198910123211505] [Cited by in Crossref: 426] [Cited by in F6Publishing: 57] [Article Influence: 12.9] [Reference Citation Analysis]
13 Janes CH, Dickson ER, Okazaki R, Bonde S, McDonagh AF, Riggs BL. Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice. J Clin Invest. 1995;95:2581-2586. [PMID: 7769100 DOI: 10.1172/jci117959] [Cited by in Crossref: 145] [Cited by in F6Publishing: 42] [Article Influence: 5.4] [Reference Citation Analysis]
14 Koulentaki M, Moscandrea J, Dimoulios P, Chatzicostas C, Kouroumalis EA. Survival of anti-mitochondrial antibody-positive and -negative primary biliary cirrhosis patients on ursodeoxycholic acid treatment. Dig Dis Sci. 2004;49:1190-1195. [PMID: 15387345 DOI: 10.1023/b:ddas.0000037811.48575.da] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
15 Neuberger J, Lombard M, Galbraith R. Primary biliary cirrhosis. Gut 1991;Suppl:S73-8. [PMID: 1916473 DOI: 10.1136/gut.32.suppl.s73] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
16 Neuberger JM, Gunson BK, Buckels JA, Elias E, McMaster P. Referral of patients with primary biliary cirrhosis for liver transplantation. Gut. 1990;31:1069-1072. [PMID: 2210454 DOI: 10.1136/gut.31.9.1069] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 1.0] [Reference Citation Analysis]
17 Taavoni M, Arashi M. Estimation in multivariate t linear mixed models for longitudinal data with multiple outputs: Application to PBCseq data analysis. Biom J 2021. [PMID: 34821410 DOI: 10.1002/bimj.202000015] [Reference Citation Analysis]
18 Tsujitani M, Tanaka Y, Sakon M. Survival data analysis with time-dependent covariates using generalized additive models. Comput Math Methods Med 2012;2012:986176. [PMID: 22545065 DOI: 10.1155/2012/986176] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
19 Todo S, Fung JJ, Starzl TE, Tzakis A, Demetris AJ, Kormos R, Jain A, Alessiani M, Takaya S, Shapiro R. Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg 1990;212:295-305; discussion 306-7. [PMID: 1697743 DOI: 10.1097/00000658-199009000-00008] [Cited by in Crossref: 161] [Cited by in F6Publishing: 149] [Article Influence: 5.0] [Reference Citation Analysis]
20 Eghtesad B, Bronsther O, Irish W, Casavilla A, Abu-Elmagd K, Van Thiel D, Tzakis A, Fung JJ, Starzl TE. Disease gravity and urgency of need as guidelines for liver allocation. Hepatology 1994;20:56S-62S. [PMID: 8005581 DOI: 10.1016/0270-9139(94)90274-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 0.0] [Reference Citation Analysis]
21 Krzeski P. Timing of transplantation for primary biliary cirrhosis. Hepatology 1999;29:609-10. [PMID: 10026027 DOI: 10.1002/hep.510290207] [Reference Citation Analysis]
22 Mansour-Ghanaei F, Taheri A, Froutan H, Ghofrani H, Nasiri-Toosi M, Bagherzadeh AH, Farahvash MJ, Mirmomen S, Ebrahimi-Dariani N, Farhangi E, Pourrasouli Z. Effect of oral naltrexone on pruritus in cholestatic patients. World J Gastroenterol 2006; 12(7): 1125-1128 [PMID: 16534857 DOI: 10.3748/wjg.v12.i7.1125] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 37] [Article Influence: 3.1] [Reference Citation Analysis]
23 Fuentealba IC, Aburto EM. Animal models of copper-associated liver disease. Comp Hepatol 2003;2:5. [PMID: 12769823 DOI: 10.1186/1476-5926-2-5] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 2.9] [Reference Citation Analysis]